Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Option Care Health (OPCH) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Option Care Health (OPCH) over the last 17 years, with Q3 2025 value amounting to $11.1 million.

  • Option Care Health's Share-based Compensation rose 689.92% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.2 million, marking a year-over-year increase of 1128.13%. This contributed to the annual value of $36.1 million for FY2024, which is 1858.33% up from last year.
  • Option Care Health's Share-based Compensation amounted to $11.1 million in Q3 2025, which was up 689.92% from $10.7 million recorded in Q2 2025.
  • In the past 5 years, Option Care Health's Share-based Compensation registered a high of $11.1 million during Q3 2025, and its lowest value of $1.2 million during Q1 2021.
  • Its 5-year average for Share-based Compensation is $6.5 million, with a median of $7.6 million in 2023.
  • Per our database at Business Quant, Option Care Health's Share-based Compensation surged by 90271.08% in 2021 and then plummeted by 837.06% in 2025.
  • Over the past 5 years, Option Care Health's Share-based Compensation (Quarter) stood at $3.3 million in 2021, then rose by 26.22% to $4.2 million in 2022, then surged by 80.18% to $7.6 million in 2023, then grew by 12.57% to $8.5 million in 2024, then surged by 30.53% to $11.1 million in 2025.
  • Its Share-based Compensation stands at $11.1 million for Q3 2025, versus $10.7 million for Q2 2025 and $8.8 million for Q1 2025.